Abnormally elevated levels of TFF3 have been documented in breast, pancreatic, gastric, and prostate carcinomas (Theisinger et al, 1996; Terris et al, 2002; Yamachika et al, 2002; Garraway et al, 2004). Here, TFF3 is linked to prostate carcinoma.